Evaluation of antibody-based preventive alternatives for respiratory syncytial virus: a novel multi-criteria decision analysis framework and assessment of nirsevimab in Spain

Respiratory syncytial virus (RSV) is a highly infectious disease that poses a significant clinical and medical burden, as well as social disruption and economic costs, recognized by the World Health Organizati...

Source: BMC Infectious Diseases - January 18, 2024 Category: Infectious Diseases Authors: Jorge Mestre-Ferr ándiz, Agustín Rivero, Alejandro Orrico-Sánchez, Álvaro Hidalgo, Fernando Abdalla, Isabel Martín, Javier Álvarez, Manuel García-Cenoz, Maria del Carmen Pacheco, María Garcés-Sánchez, Néboa Zozaya and Raúl Ortiz-de-Lejarazu Tags: Research Source Type: research